Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS

Environmentally Relevant Human Exposure to Micro- and Nanoplastics: Inflammatory Effects through Mechanistic Insights, Clinical Validation, and Predictive Modelling

Objetivo

Human exposure to micro- and nanoplastics (MNPs) and their additives is an emerging concern with potential links to chronic inflammation, immune dysfunction, and systemic diseases. However, causal evidence in humans remains scarce due to the lack of validated models, toxicity protocols tailored to MNPs, analytical limitations, and poor mechanistic understanding. MACsym will systematically investigate how MNP physicochemical properties influence their bioavailability, toxicokinetics, and toxicodynamics, focusing on how MNPs cross physiological barriers, undergo biodistribution and biotransformation, and trigger inflammatory responses at sites of action, including the synergistic effects of MNPs and additives. In parallel, biomonitoring and biomarker analyses will be carried out in (i) occupational cohorts to identify dominant exposure pathways, (ii) the general population to capture background exposure, and (iii) patients with inflammation-driven diseases to link MNP burdens and biomarkers with clinical outcomes. The resulting data will feed into predictive models, enabling extrapolation to other MNPs and additives, providing early-warning capacity, and improving biodistribution estimation to assess whether MNP accumulation can be predicted without experimental testing. To ensure reliability, MACsym will develop stepwise methods for sampling, sample preparation, and characterisation of MNPs tailored to human samples. This will be supported by reference materials and validated quality assurance and quality control workflows to minimise contamination. Its FAIR-by-design approach ensures regulatory relevance, public health utility, and integration into EU risk assessment systems. The project’s outputs will support standardisation, biomonitoring, and safer material innovation, reinforcing EU leadership in addressing MNP-related health risks.

Ámbito científico (EuroSciVoc)

Este proyecto aún no se ha clasificado con EuroSciVoc.
Sugiera los ámbitos científicos que considere más relevantes y ayúdenos a mejorar nuestro servicio de clasificación.

Palabras clave

Programa(s)

Tema(s)

Régimen de financiación

HORIZON-RIA - HORIZON Research and Innovation Actions

Ver todos los proyectos financiados en el marco de este régimen de financiación

Convocatoria de propuestas

(se abrirá en una nueva ventana) HORIZON-HLTH-2025-03-two-stage

Ver todos los proyectos financiados en el marco de esta convocatoria

Coordinador

UNIVERSITA DEGLI STUDI DI PADOVA
Aportación neta de la UEn
€ 1 154 075,00
Coste total
Sin datos

Participantes (18)